Open Access

Correlation between Bax gene polymorphisms and esophagus cancer

  • Authors:
    • Lei Sun
    • Lingyun Wei
    • Lei Wei
    • Demin Li
  • View Affiliations

  • Published online on: September 27, 2018     https://doi.org/10.3892/ol.2018.9511
  • Pages: 7097-7101
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated the association between the G(‑248)A single nucleotide polymorphism (SNP) in the promoter region of B‑cell lymphoma 2 (Bcl‑2) associated X protein (Bax), which is a pro‑apoptosis gene and the clinicopathological parameters and prognosis of patients with esophagus cancer. Three genotypes (AA, AG and GG) of Bax G(‑248)A SNP were detected in 75 patients with esophageal squamous cell carcinoma (ESCC) via polymerase chain reaction‑restricted fragment length polymorphism (PCR‑RFLP). The expression of Bax in tumor tissues from 75 patients with ESCC and 30 para‑carcinoma normal tissues were detected via immunohistochemistry. The association between the Bax protein expression and the Bax gene polymorphism was analyzed via the χ2 test. The clinical data of patients was collected and the association between Bax gene polymorphism and the pathological parameters and the prognosis of patients with ESCC was analyzed. The PCR‑RFLP results revealed that the number of cases and the distribution frequencies of GG, AG and AA genotypes of Bax polymorphism in patients with ESCC were 50 (66.67%), 16 (21.33%) and 9 (12%), respectively. The immunohistochemical results revealed that the positive expression rate of Bax in ESSC tissues was 42.67%. Bax protein expression was associated with the Bax gene polymorphism, which was associated with outer membrane infiltration, differentiation degree, lymphatic metastasis and the clinical staging of patients. The overall 5‑year survival rate of patients was 38.6% (29/75). The survival analyses revealed that the prognosis of patients with AG+AA genotypes was favorable, while that of patients with GG genotype was poor. Bax gene polymorphism was associated with Bax gene expression, tumor staging and lymphatic metastasis in patients with ESCC, which is an influencing factor for the overall survival rate and may be used as a reference index for the prognosis evaluation of patients with ESCC.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 16 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun L, Wei L, Wei L and Li D: Correlation between Bax gene polymorphisms and esophagus cancer. Oncol Lett 16: 7097-7101, 2018
APA
Sun, L., Wei, L., Wei, L., & Li, D. (2018). Correlation between Bax gene polymorphisms and esophagus cancer. Oncology Letters, 16, 7097-7101. https://doi.org/10.3892/ol.2018.9511
MLA
Sun, L., Wei, L., Wei, L., Li, D."Correlation between Bax gene polymorphisms and esophagus cancer". Oncology Letters 16.6 (2018): 7097-7101.
Chicago
Sun, L., Wei, L., Wei, L., Li, D."Correlation between Bax gene polymorphisms and esophagus cancer". Oncology Letters 16, no. 6 (2018): 7097-7101. https://doi.org/10.3892/ol.2018.9511